Medications for Brain Diseases

9 results

  • Clariscan (gadoterate meglumine)

    (gadoterate meglumine)
    GE Healthcare
    Usage: Clariscan is a gadolinium-based contrast agent used for intravenous administration during MRI to detect and visualize disruptions in the blood-brain barrier and abnormal vascularity in the brain, spine, and associated tissues in both adult and pediatric patients, including term neonates.

  • Dotarem (gadoterate meglumine)

    (gadoterate meglumine)
    Guerbet LLC
    Usage: DOTAREM is a gadolinium-based contrast agent used intravenously with MRI to detect and visualize abnormalities in the brain, spine, and associated tissues in both adults and pediatric patients, including term neonates, particularly to identify disruptions in the blood-brain barrier and abnormal vascularity.

  • Gadoterate meglumine (gadoterate meglumine)

    (gadoterate meglumine)
    Fresenius Kabi USA, LLC
    Usage: Gadoterate Meglumine Injection is a gadolinium-based contrast agent indicated for intravenous use during MRI to detect and visualize disruptions of the blood-brain barrier and abnormal vascularity in the brain, spine, and associated tissues in both adult and pediatric patients, including term neonates.

  • Gadoterate meglumine (gadoterate meglumine)

    (gadoterate meglumine)
    Fresenius Kabi USA, LLC
    Usage: Gadoterate Meglumine Injection is a gadolinium-based contrast agent used in MRI for adults and pediatric patients (including term neonates) to visualize brain, spine, and associated tissues, enabling detection of blood-brain barrier disruptions and abnormal vascularity.

  • Glucoheptonate (glucoheptonate)

    (Glucoheptonate)
    AnazaoHealth Corporation
    Usage: Tc 99m Glucoheptonate is indicated for imaging of the kidney and brain, as well as for assessing renal and brain perfusion.

  • Omniscan (gadodiamide)

    (gadodiamide)
    GE Healthcare Inc.
    Usage: OMNISCAN is a gadolinium-based contrast agent indicated for intravenous use in MRI to visualize lesions with abnormal vascularity in the brain, spine, and associated tissues, as well as in the thoracic (noncardiac), abdominal, pelvic, and retroperitoneal regions.

  • Omniscan (gadodiamide)

    (gadodiamide)
    GE Healthcare Inc.
    Usage: OMNISCAN is a gadolinium-based contrast agent for intravenous use in MRI, indicated for visualizing lesions with abnormal vascularity in the brain, spine, and associated tissues, as well as in the thoracic (noncardiac), abdominal, pelvic, and retroperitoneal regions.

  • Prohance (gadoteridol)

    (gadoteridol)
    Bracco Diagnostics Inc
    Usage: ProHance is indicated for magnetic resonance imaging (MRI) in adults and pediatric patients, including neonates, to visualize intracranial lesions with disrupted blood-brain barrier or abnormal vascularity, as well as lesions in extracranial/extraspinal tissues in the head and neck.

  • Prohance (gadoteridol)

    (gadoteridol)
    BRACCO DIAGNOSTICS INC
    Usage: ProHance is indicated for magnetic resonance imaging (MRI) in adults and pediatric patients, including term neonates. It helps visualize lesions with disrupted blood-brain barrier and abnormal vascularity in the brain, spine, and associated tissues, as well as lesions in the head and neck.